Related Experiment Video
Updated: Jan 31, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Apolipoprotein E4 and its later-life health effects on the multiple sclerosis population
Dean Zeldich1, Chia Hsin Cheng2, Yi Guan2
1Department of Neurology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Background And Objectives:
Multiple sclerosis (MS) is a chronic autoimmune disease causing neuroinflammation and neurodegeneration. The apolipoprotein E4 (APOE4) allele, a major genetic risk factor for late-onset Alzheimer's Disease, accelerates cognitive decline and neuroinflammatory processes, including blood-brain-barrier disruption. This study explores the impact of APOE4 on later-life health in MS patients using biomarkers from the UK Biobank.
Methods:
MS patients were grouped by APOE4 carrier status: MS-E4 and MS-nonE4. Age- and sex-matched non-MS controls (control-E4, control-nonE4) were included for comparison. Analyses assessed retinal nerve fiber layer thickness (RNFL) from optical coherence tomography (OCT), blood biomarkers, cognitive performance, and brain magnetic resonance imaging (MRI) metrics.
Results:
MS-E4 patients exhibited worse outcomes, including thinner RNFL, higher blood glial fibrillary acidic protein (GFAP) and neurofilament light chain levels, slower cognitive reaction times, and more white matter hyperintensities. GFAP had significant interactions between MS and APOE4 status, correlating with neurodegenerative markers.
Discussion:
APOE4 exacerbates neurodegeneration and neuroinflammation in MS, evident in retinal OCT, cognitive testing, and MRI findings. Similar effects were observed in healthy APOE4 carriers. These results highlight the utility of multi-domain biomarkers for MS diagnosis and long-term management, emphasizing less invasive tools for monitoring disease progression.
Insights
The apolipoprotein E4 (APOE4) allele worsens neuroinflammation and neurodegeneration in multiple sclerosis (MS) patients. This genetic factor exacerbates MS progression, impacting cognitive function and brain health, as shown by multi-domain biomarkers.
Area of Science:
- Neuroimmunology
- Genetics
- Neurology
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease characterized by neuroinflammation and neurodegeneration.
- The apolipoprotein E4 (APOE4) allele is a significant genetic risk factor for Alzheimer's Disease, known to accelerate cognitive decline and neuroinflammatory processes.
Purpose of the Study:
- To investigate the impact of the APOE4 allele on the health outcomes of multiple sclerosis patients.
- To explore the role of APOE4 in exacerbating neurodegeneration and neuroinflammation in the context of MS.
Main Methods:
- Utilized UK Biobank data, grouping MS patients by APOE4 carrier status (MS-E4 vs. MS-nonE4).
- Included age- and sex-matched non-MS controls (control-E4 vs. control-nonE4).
- Assessed retinal nerve fiber layer thickness (RNFL) via OCT, blood biomarkers (GFAP, NfL), cognitive performance, and brain MRI metrics.
Main Results:
- MS patients with the APOE4 allele (MS-E4) showed poorer outcomes: thinner RNFL, elevated GFAP and NfL, slower cognitive reaction times, and increased white matter hyperintensities.
- Glial fibrillary acidic protein (GFAP) levels demonstrated significant interactions between MS and APOE4 status, correlating with neurodegenerative markers.
- Similar detrimental effects of APOE4 were observed in healthy control individuals.
Conclusions:
- APOE4 significantly exacerbates neurodegeneration and neuroinflammation in MS patients.
- Multi-domain biomarkers, including retinal OCT, cognitive tests, and MRI, are valuable for monitoring MS progression.
- Less invasive biomarkers show promise for tracking disease advancement in MS.
Related Concept Videos
Characteristics of Life
Half-life of a Reaction
Conservation of Small Populations
The Angiosperm Life Cycle
What is Population Genetics?
Population Growth

